Literature DB >> 22142519

Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice.

Piera Boschetto1, Bianca Beghé, Leonardo M Fabbri, Claudio Ceconi.   

Abstract

Chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD) are global epidemics that incur significant morbidity and mortality. These diseases are frequently found in combination, and they can also be found independent of the common causal factors, primarily smoking. Both conditions are systemic disorders with overlapping mechanisms and pathophysiologic processes. CAD has a strong effect on the severity and prognosis of COPD and vice versa, including acute exacerbations. Even the most recent practical clinical recommendations driven by Clinical Practice Guidelines still focus on one disease at a time, and do not provide advice for the management of patients with associated chronic conditions. COPD should be approached in a more comprehensive manner, including the treatment of cardiac comorbidities, particularly CAD. To focus treatment on these comorbidities might modify the natural course of the disease in patients with COPD who may not find relief from treatment of COPD alone.
© 2011 The Authors. Respirology © 2011 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Year:  2012        PMID: 22142519     DOI: 10.1111/j.1440-1843.2011.02118.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  19 in total

Review 1.  Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.

Authors:  Michael Schivo; Timothy E Albertson; Angela Haczku; Nicholas J Kenyon; Amir A Zeki; Brooks T Kuhn; Samuel Louie; Mark V Avdalovic
Journal:  J Investig Med       Date:  2017-03-03       Impact factor: 2.895

Review 2.  Strategies for reducing the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease.

Authors:  Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-02-06

3.  Obesity-induced adipokine imbalance impairs mouse pulmonary vascular endothelial function and primes the lung for injury.

Authors:  Dilip Shah; Freddy Romero; Michelle Duong; Nadan Wang; Bishnuhari Paudyal; Benjamin T Suratt; Caleb B Kallen; Jianxin Sun; Ying Zhu; Kenneth Walsh; Ross Summer
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

4.  Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis.

Authors:  Ning Xia; Hao Wang; Xiuhong Nie
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

5.  Increased serum ox-LDL levels correlated with lung function, inflammation, and oxidative stress in COPD.

Authors:  Yongchun Shen; Ting Yang; Shujin Guo; Xiao'ou Li; Lei Chen; Tao Wang; Fuqiang Wen
Journal:  Mediators Inflamm       Date:  2013-09-01       Impact factor: 4.711

6.  Electronic health records and improved nursing management of chronic obstructive pulmonary disease.

Authors:  Fengping Liu; Yeqing Zou; Qingmei Huang; Li Zheng; Wei Wang
Journal:  Patient Prefer Adherence       Date:  2015-03-24       Impact factor: 2.711

7.  Arterial stiffness in symptomatic smokers with normal lung function.

Authors:  Nicola Scichilone; Antonino Tuttolomondo; Carlo Maida; Alida Benfante; Jessica Peluso; Anna Cirrincione; Valerio Vassallo; Antonio Pinto
Journal:  ERJ Open Res       Date:  2017-07-21

Review 8.  Chronic obstructive pulmonary disease.

Authors:  V K Vijayan
Journal:  Indian J Med Res       Date:  2013-02       Impact factor: 2.375

9.  Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF: an observational study.

Authors:  Bianca Beghé; Alessia Verduri; Barbara Bottazzi; Mariarita Stendardo; Alessandro Fucili; Sara Balduzzi; Chiara Leuzzi; Alberto Papi; Alberto Mantovani; Leonardo M Fabbri; Claudio Ceconi; Piera Boschetto
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease.

Authors:  Beti Zafirova-Ivanovska; Jagoda Stojkovikj; Dejan Dokikj; Sasha Anastasova; Angela Debresliovska; Sead Zejnel; Dragana Stojkovikj
Journal:  Open Access Maced J Med Sci       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.